Skip to main content

Affiliate disclosure: We may earn a commission if you buy through links on this site — at no extra cost to you. Thanks!

How to Get GLP-1 Medications Safely Online: Complete 2026 Safety Guide

By WPG Research TeamPublished: Last updated:

Disclosure: Some links on this site are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you. Thank you for supporting our site.·For informational purposes only—not medical advice.

Learn how to safely get GLP-1 medications online. Verify providers, avoid scams, understand FDA warnings, and find legitimate telehealth clinics for semaglutide.

Quick Answer

Getting GLP-1 medications safely online requires working with licensed telehealth providers who conduct legitimate medical evaluations, use state-licensed pharmacies, and follow FDA guidelines. In September 2025, the FDA issued over 50 warning letters to companies making false claims about compounded GLP-1 products—a clear signal that not all online sources are trustworthy. To protect yourself, verify that any provider requires a prescription from a licensed healthcare professional, uses pharmacies you can confirm through your state board of pharmacy, and doesn't make claims that compounded products are "the same as" FDA-approved medications.

Quick Safety Checklist: Is Your Online GLP-1 Provider Legitimate?

Before purchasing from any online provider, verify these five criteria:

Safety CheckWhat to Look ForRed Flag
Prescription RequiredMedical questionnaire + provider review before prescribingNo prescription needed, "research use only"
Licensed ProvidersU.S.-licensed physicians or nurse practitionersNo provider credentials listed
Pharmacy VerificationState-licensed pharmacy you can verifyOverseas shipping, no pharmacy information
CertificationLegitScript certified for telehealthCannot advertise on Google/Meta, unlisted
Transparent PricingClear costs disclosed before purchaseHidden fees, prices "too good to be true"

If a provider fails any of these checks, do not purchase from them.

What the FDA Says About Getting GLP-1s Online

The FDA has issued multiple safety communications about purchasing GLP-1 medications online. Understanding their official guidance is essential before choosing any provider.

FDA-Approved vs. Compounded: A Critical Distinction

FDA-Approved GLP-1 Medications

The only FDA-approved semaglutide products are Ozempic, Wegovy, and Rybelsus (manufactured by Novo Nordisk). The only FDA-approved tirzepatide products are Mounjaro and Zepbound (manufactured by Eli Lilly).

These medications have undergone rigorous review for safety, effectiveness, and manufacturing quality.

Compounded GLP-1 Medications

Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies using the active pharmaceutical ingredients.

According to the FDA: "Compounded drugs are not approved by FDA. This means the agency does not review compounded drugs for safety, effectiveness, or quality before they are marketed."

The FDA's position is clear: "Compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug."

September 2025 Warning Letters

In September 2025, the FDA issued over 50 warning letters to telehealth companies and compounders for false and misleading claims. The primary violations included:

  • Claims that compounded products are "generic versions" of FDA-approved drugs
  • Claims that compounded products contain the "same active ingredient" and have equivalent safety/efficacy
  • Claims of "clinically proven" or "real results" for compounded products

Shortage Status and Compounding Regulations

As of February 2025, the FDA declared the national shortage of semaglutide injection products resolved. As of December 2024, the tirzepatide shortage was also resolved. This determination affects when compounding of these medications is permitted under federal law.

The FDA states it "may still take action regarding violations of any other statutory or regulatory requirements, such as to address findings that a product may be of substandard quality or otherwise unsafe."

How to Verify a Legitimate Online GLP-1 Provider

Step 1: Check for LegitScript Certification

LegitScript is the industry-standard certification for online healthcare providers. Major platforms including Google, Meta, Visa, and Mastercard require LegitScript certification for pharmacies and telehealth companies selling prescription medications.

What LegitScript certification means:

  • The provider has been independently verified for licensing and compliance
  • Business practices have been reviewed for transparency
  • The company can legally advertise prescription medications online
  • Payment processors recognize the business as legitimate

Important: LegitScript certification verifies operational legitimacy—it does not mean the FDA has approved the medications being sold.

Step 2: Verify State Pharmacy Licensing

The FDA's BeSafeRx campaign provides tools to verify pharmacy licensing. Before purchasing:

  1. Go to FDA.gov/BeSafeRx
  2. Click on your state to access your state board of pharmacy database
  3. Search for the pharmacy by name
  4. Confirm the pharmacy is licensed in your state

If the pharmacy isn't listed in your state's database, do not use that pharmacy.

Step 3: Confirm Provider Credentials

Legitimate telehealth platforms work with licensed healthcare providers who can legally prescribe medications in your state. Verify:

  • Provider names and credentials are listed on the website
  • NPI numbers (National Provider Identifier) can be verified at nppes.cms.hhs.gov
  • State medical licenses can be checked through your state medical board

Step 4: Evaluate the Medical Evaluation Process

A legitimate provider will conduct an appropriate medical evaluation before prescribing. This should include:

  • Comprehensive health questionnaire covering medical history, current medications, allergies, and contraindications
  • BMI calculation and verification of eligibility criteria
  • Discussion of side effects and risks
  • Option for follow-up care and dose adjustments

Red flags in the evaluation process:

  • Approval in minutes without meaningful medical review
  • No questions about contraindications (thyroid cancer history, pancreatitis, pregnancy)
  • Prescribing without verifying any health information

Step 5: Understand What You're Getting

Before purchasing, confirm exactly what medication you'll receive:

  • FDA-approved branded medication (Ozempic, Wegovy, Zepbound, etc.) OR
  • Compounded medication from a licensed compounding pharmacy

If compounded, verify:

  • Which compounding pharmacy prepares the medication
  • Whether the pharmacy follows USP 795 and 797 standards
  • How the medication will be shipped (temperature-controlled packaging is essential)
  • What concentration and format you'll receive

Clinical Eligibility: Who Qualifies for GLP-1 Medications?

Understanding clinical eligibility helps you avoid providers who prescribe inappropriately.

FDA-Approved Indications

For Wegovy (semaglutide) and Zepbound (tirzepatide) for weight management:

  • BMI of 30 or greater (obesity), OR
  • BMI of 27-29.9 (overweight) with at least one weight-related condition

Weight-related conditions that may qualify you:

  • Type 2 diabetes
  • High blood pressure (hypertension)
  • High cholesterol (dyslipidemia)
  • Sleep apnea
  • Cardiovascular disease
  • Polycystic ovary syndrome (PCOS)

Who Should NOT Take GLP-1 Medications

Legitimate providers will screen for contraindications including:

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis
  • Current pregnancy or planning to become pregnant
  • Breastfeeding
  • Severe gastrointestinal disease
  • Allergy to semaglutide, tirzepatide, or any product components

If a provider doesn't ask about these conditions, that's a serious red flag.

FDA-Identified Safety Concerns with Online GLP-1 Sources

The FDA has documented specific problems with compounded GLP-1 products purchased online:

Dosing Errors

According to the FDA: "FDA received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products."

These errors resulted from:

  • Patients measuring and self-administering incorrect doses
  • Healthcare professionals miscalculating doses
  • Confusing instructions (e.g., measuring in "units" rather than milligrams)
  • Varying concentrations between compounders

Temperature and Storage Issues

The FDA states: "FDA has received complaints that certain compounded GLP-1 drugs have arrived warm or with inadequate ice packs to keep the drug at recommended storage temperatures."

Recommendation: "Patients should not use any injectable GLP-1 drug that arrives warm or with insufficient refrigeration, as this can affect the drug's quality."

Quality Control Concerns

A 2025 pharmacovigilance study published in Expert Opinion on Drug Safety analyzed FDA Adverse Event Reporting System (FAERS) data from 2018-2024. The findings revealed:

  • Compounded GLP-1 receptor agonists had higher likelihood of reported adverse effects
  • Prescribing and preparation errors were reported more frequently for compounded medications
  • Hospitalization associated with adverse effects was reported more frequently in the compounded group

Source: McCall et al., "Safety analysis of compounded GLP-1 receptor agonists," Expert Opinion on Drug Safety, April 2025

Prohibited Substances

The FDA warns: "Retatrutide and cagrilintide cannot be used in compounding under federal law. Additionally, these are not components of FDA-approved drugs and have not been found safe and effective for any condition."

If you see these substances offered, the provider is operating illegally.

Red Flags: How to Spot Unsafe Online GLP-1 Sellers

Immediate Disqualifiers

Do not purchase from any provider that:

  • Sells without requiring a prescription
  • Ships from outside the United States
  • Labels products "for research use only" or "not for human consumption"
  • Cannot identify their pharmacy partner
  • Offers prices dramatically below market rates (under $100/month should raise concerns)
  • Claims compounded products are "identical to" or "generic versions of" FDA-approved medications
  • Guarantees specific weight loss results
  • Doesn't ask about medical history or contraindications

Warning Signs in Marketing

The FDA specifically targeted these false claims in their September 2025 warning letters:

  • "Same active ingredient as Ozempic/Wegovy"
  • "Clinically proven ingredients"
  • "Generic semaglutide"
  • "FDA-approved ingredients" (misleading because the compounded product itself is not FDA-approved)
  • Claims of equivalent safety and efficacy to branded medications

Website Quality Indicators

Legitimate Providers Have:

  • Clear contact information (U.S. phone number and physical address)
  • Named medical leadership with verifiable credentials
  • Transparent pricing before you begin
  • Privacy policy and HIPAA compliance statements
  • Detailed FAQ sections about their process
  • Information about their pharmacy partners

Unsafe Sellers Often Have:

  • No U.S. physical address
  • Contact only via email or chat
  • Pricing revealed only after submitting personal information
  • Poor grammar or spelling errors
  • Stock photos instead of actual team photos
  • No information about pharmacy sourcing

Step-by-Step: How to Safely Get GLP-1 Medications Online

Step 1: Determine Your Eligibility

  • Calculate your BMI using height and weight (CDC BMI calculator is free and reliable)
  • Identify any weight-related conditions you have been diagnosed with
  • Review contraindications to ensure you don't have disqualifying conditions
  • Consider your commitment to lifestyle changes alongside medication

Step 2: Choose Your Medication Path

Option A: FDA-Approved Brand-Name

  • Higher cost ($350-$1,350+ per month without insurance)
  • Standardized manufacturing and quality
  • Established clinical trial data

Option B: Compounded Medications

  • Lower cost ($179-$399 per month typically)
  • Not FDA-approved as finished products
  • Variable manufacturing standards

Step 3: Research Providers

For compounded medications:

  • Verify LegitScript certification
  • Confirm pharmacy licensing
  • Research provider reputation (Better Business Bureau, Trustpilot)
  • Check for recent FDA warning letters to the provider

Step 4: Complete the Medical Evaluation

A legitimate evaluation should include:

  • Health questionnaire (15-30+ questions is typical for thorough screening)
  • Medical history review by a licensed provider
  • Discussion of goals and expectations
  • Review of potential side effects and risks
  • Prescription decision based on medical appropriateness

Step 5: Verify Your Shipment

When your medication arrives, check:

  • Shipped in temperature-controlled packaging with cold packs
  • Packaging is intact and not damaged
  • Labels are in English with clear dosing instructions
  • Expiration date is clearly visible and not expired
  • Includes all necessary supplies (needles, alcohol swabs if injectable)

If anything seems wrong: Do not use the medication. Contact the provider immediately. Report concerns to FDA MedWatch if you suspect a safety issue.

Step 6: Establish Ongoing Care

Safe GLP-1 therapy requires monitoring. Confirm your provider offers:

  • Dose titration guidance as you increase from starting dose
  • Side effect management support
  • Regular check-ins (monthly or quarterly)
  • Access to providers via messaging or phone for questions

Where to Report Problems

If you experience issues with online GLP-1 purchases, report them:

FDA MedWatch

Report adverse events, quality problems, or suspected counterfeit products:

  • Online: FDA.gov/MedWatch
  • Phone: 1-800-FDA-1088

State Board of Pharmacy

Report pharmacy-related complaints to your state's board of pharmacy (find contact information at FDA.gov/BeSafeRx)

Federal Trade Commission (FTC)

Report deceptive advertising or business practices: ReportFraud.FTC.gov

Key Resources for Verification

FDA Resources

  • BeSafeRx Campaign: FDA.gov/BeSafeRx
  • FDA's Concerns with GLP-1 Drugs: FDA.gov
  • Report Problems: FDA.gov/MedWatch

Provider Verification

  • LegitScript Verification: LegitScript.com
  • NABP Buy Safely: safe.pharmacy
  • State Medical Board Lookup: fsmb.org

Bottom Line: Protecting Yourself When Buying GLP-1s Online

The demand for GLP-1 weight loss medications has created opportunities for both legitimate telehealth providers and dangerous scammers. Protecting yourself requires due diligence:

  • Verify every provider using FDA tools, LegitScript, and state licensing databases
  • Understand what you're buying—know whether you're getting FDA-approved or compounded medication
  • Never purchase without a prescription from a properly licensed provider
  • Inspect your medication when it arrives and don't use anything that seems wrong
  • Establish ongoing care with providers who will monitor your health throughout treatment

Your health is too important to gamble with unverified online sources. Take the time to verify before you buy.

Find a Verified Provider

We have researched providers that meet safety standards. Compare options and find the right fit for your needs.

Compare Verified Providers

Related Content

Safety Questions

Yes, if you obtain them through a legitimate telehealth provider with a valid prescription from a licensed healthcare professional, filled by a state-licensed pharmacy. Purchasing without a prescription, from overseas sources, or from unlicensed sellers is illegal and potentially dangerous.

Compounded medications prepared by licensed U.S. pharmacies following USP standards can be safe when prescribed appropriately. However, the FDA does not review compounded products for safety, effectiveness, or quality before they are marketed. Studies have shown higher rates of adverse events and dosing errors with compounded GLP-1s compared to FDA-approved products.

Use the FDA's BeSafeRx tools to verify state licensing. Check for LegitScript certification. Confirm the pharmacy requires a prescription, has a U.S. address and phone number, and has a licensed pharmacist available to answer questions. If any of these elements are missing, do not use that pharmacy.

Do not use medication that arrives warm, damaged, or with insufficient refrigeration. Contact the provider immediately for a replacement. Report quality concerns to FDA MedWatch. Injectable GLP-1 medications require proper cold chain handling to maintain effectiveness.

No. All GLP-1 medications—both FDA-approved and compounded—require a prescription from a licensed healthcare provider. Any seller offering these medications without a prescription is operating illegally and may be selling counterfeit or dangerous products.

Compounded medications are prepared by pharmacies using bulk active pharmaceutical ingredients rather than finished manufactured products. They don't incur the same research, development, and marketing costs as brand-name drugs. However, they also haven't undergone the same FDA review process for safety, effectiveness, and quality.

503A pharmacies compound medications based on individual patient prescriptions. 503B pharmacies (outsourcing facilities) can compound larger quantities without patient-specific prescriptions and are subject to FDA oversight, including current good manufacturing practice (CGMP) requirements. Both are regulated, but 503B facilities have more stringent FDA oversight.

FDA-approved criteria include: BMI of 30 or higher, OR BMI of 27-29.9 with at least one weight-related condition (such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea). A legitimate provider will evaluate your complete medical history, not just your BMI, to determine if GLP-1 therapy is appropriate and safe for you.

Related Articles